I agree We use cookies on this website to help us provide the best user experience. By browsing this site you agree to their use - more information is available here.

Barnett Waddingham
0333 11 11 222

Blog: Longevity services

Making predictions just got harder

Question marks over our ability to predict the future provided two of the highlights of our recent annual pensions conference. Senior Partner Nick Salter explores...

Solvency II: longevity risk and spurious parameters

For a recent survey, Barnett Waddingham gathered information on Solvency II capital requirements for longevity from eight internal model firms and we found significant variations in assumptions.

Slower start for bulk annuities in 2016

Our recently released report on the state of play in the bulk annuity market, Barnett Waddingham’s Bulk Annuity Annual Report 2016, examines the latest developments in the market.

Equity release mortgages: taming the super-asset?

Scott Eason and Michael Henderson explore the potential implications of the PRA’s announcement to undertake a review of Equity Release Mortgages.

Standard Formula Calculations made simple

With the Solvency II implementation date looming, firms must make sure their processes are ready to meet the requirements. We explore how a standard formula Solvency Capital Requirement calculation tool can be made as simple as possible for the end user.

Understanding and comparing longevity projections

This blog post was written by Dave Grimshaw and Jon Palin who discussed and compared a range of methods for projecting future improvements in mortality at the IFoA’s Life Conference on 20 November. The session was aimed at delegates without specialist longevity expertise, who need to assess proposed assumptions.

Raise the alarm! The worrying rise in antimicrobial resistance

Rewind to 1900 and infectious diseases were the second biggest cause of death in England and Wales. By 1960, deaths from infectious diseases were all but eradicated.

A Smoking Gun for Female Mortality Improvements?

It is common knowledge that smoking is the primary catalyst for lung cancer, the second and sixth highest cause of death for males and females respectively in 2012 . However, male and female mortality has been affected differently by changing prevalence of smoking.

Does smoking affect mortality improvements?

Smoking kills. No surprises there. It has also been recognised in the pricing of term insurance in the UK since the early 1980s and more recently in annuity pricing. But what do we know about the impact of smoking on mortality improvements?

Mortality improvements by cause of death

After many years of rapid mortality improvements in the UK population, 2012 and 2013 saw significantly lower gains.

Updates delivered to you

Stay ahead with our latest comment, expert insight and event details.